Neurology Archives - Page 6 of 10

Maintaining adherence programme: evaluation of an innovative service model

Authors: L Lewis, C O’Keeffe, I Smyth, J Mallalieu, L Baldock, S Oliver Published: BJPsych Bulletin, 2016 View publication Aims and Method The Maintaining Adherence Programme (MAP) is a new model of...

A three month interim analysis of Treatment satisfaction with Fingolimod in patients with relapsing remitting multiple sclerosis in the UK: the Patient Reported Outcomes with Fingolimod in local Experience (PROFILE) study

Authors: Adlard N, Brisbane F, Watson J, Bishop-Bailey A, Kroes M Published: Value in Health, 2017 View publication Objectives The PROFILE study measured patient reported outcomes (PROs) in the real world in...

The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis

Authors: J Datt, L Baldock, E Pull, B Webber Published: Multiple sclerosis and related disorders, 2016 View publication Background Patients initiated on Gilenya (fingolimod) require cardiovascular monitoring for 6h after the first...

A discrete choice experiment to determine UK patient preference for attributes of disease modifying treatments in Multiple Sclerosis

Authors: C Bottomley, A Lloyd, G Bennett, N Adlard Published: Journal of medical economics, 2017 View publication Aims The recent licensing of Disease Modifying Treatments (DMTs) for Multiple Sclerosis (MS) has increased...

Discussing multiple sclerosis (MS) progression with patients: experiences of UK healthcare professionals from the SPECTRUM project

Authors: M Duddy, C Wilkinson, K Rhys, S Medhurst Published: 2020 View publication Abstract Background: Receiving a diagnosis of secondary progressive multiple sclerosis (SPMS) can have a significant psychological impact on patients....

Health utilities associated with treatment-resistant depression in UK patients and their caregivers

Authors: T Denee, C Kerr, M Desai, J Eva, S Rathod Published: 2020 View publication This study assessed major depressive disorder (MDD) and treatment-resistant depression (TRD) patient and carer health utilities in...

A three month interim analysis of fingolimod treatment adherence for relapsing remitting Multiple Sclerosis in the UK: The Patient Reported Outcomes with Fingolimod in local experience (PROFILE) study

Authors: N Adlard, J Watson, C Bottomley, M Kroes Published: Value in health, 2018 View publication Objectives The PROFILE study measured patient reported outcomes (PROs) in the real world in fingolimod-treated patients...

UK Patient Preference for Characteristics of Disease Modifying Treatments in Multiple Sclerosis

Authors: Bottomley CJ, Padania S, Lloyd AJ, Bennett G, Green C, Adlard N Published: Journal of Neurology, Neurosurgery & Psychiatry, 2016 View publication Abstract With recent Disease Modifying Treatments (DMTs) licensed in...

Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson’s disease: results from a pooled meta-analysis

Authors: D G Standaert, V Patel, S J Snedecor, S Thakkar, Y J Jalundhwala, P Kukreja, D Kratochvil, Y Bao, R Pahwa Published: Parkinsonism & Related Disorders, 2021 View publication Introduction To...

News